Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

ClinicalTrials.gov ID: NCT00228605

Public ClinicalTrials.gov record NCT00228605. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label 12 Month Study to Evaluate the Safety, Tolerability and Efficacy of OraVescent Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Noncancer Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl for the potential treatment of breakthrough pain episodes in patients who have chronic noncancer pain.

Study identification

NCT ID
NCT00228605
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
500 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2005 (Type not available)
Primary completion
Not listed
Completion
May 2007 (Actual)
Last update posted
May 9, 2014

2005 – 2007

United States locations

U.S. sites
38
U.S. states
23
U.S. cities
32
Facility City State ZIP Site status
MedSearch Calera Alabama 35040 —
Clinical Research Consultants, Inc. Hoover Alabama 35216 —
Arizona Research Center Phoenix Arizona 85023 —
NEA Clinic Jonesboro Arkansas 72404 —
Lynn Institute of the Rockies Colorado Springs Colorado 80909 —
Radiant Research-Daytona Beach Daytona Beach Florida 32114 —
Advent Clinical Research Centers, Inc. St. Petersburg Florida 33703 —
Gold Coast Research Weston Florida 33331 —
Center for Prospective Outcome Studies, Inc. Atlanta Georgia 30327 —
Advent Clinical Research Centers, Inc. Atlanta Georgia 30342 —
Center for Prospective Outcome Studies, Inc. Marietta Georgia 30060 —
North Fulton Regional Hospital Pain Center Roswell Georgia 30076 —
Carmen Research Smyrna Georgia 30080 —
Orthopedic Health Care Boise Idaho 83702 —
Medisphere Medical Research Center, LLC Evansville Indiana 47714 —
Tri-State Arthritis & Rheumatology Center, LLC Evansville Indiana 47714 —
Iowa Pain Management Clinic, PC Des Moines Iowa 50265 —
Mid-America Physiatrists, PA Overland Park Kansas 66211 —
Capital Clinical Research Associates, LLC Rockville Maryland 20852 —
Brigham Women's Hospital, Attn: Pain Trials Center Boston Massachusetts 02115 —
MedVadis Research Wellesley Hills Massachusetts 02481-2106 —
Medex Healthcare Research Center St Louis Missouri 63108 —
Radiant Research - St. Louis St Louis Missouri 63141 —
Clinical Research Center of Nevada Las Vegas Nevada 89104 —
Northshore University Hospital Bethpage New York 11714 —
NYU Pain Management Center New York New York 10016 —
Research Across America New York New York 10022 —
The Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Southern Oregon Health & Wellness Medford Oregon 97504 —
Clinical Research Center of Reading, LLP West Reading Pennsylvania 19611 —
Healthstar Physicians Morristown Tennessee 37813 —
Biopharma Research Associates Sugar Land Texas 77479 —
Lifetree Clinical Research Salt Lake City Utah 84106 —
Radiant Research Salt Lake City Utah 84107 —
Huntsman Cancer Institute Salt Lake City Utah 84112 —
Pain Management Center South Burlington Vermont 05403 —
Northwest Clinical Research Center Bellevue Washington 98004 —
Rowan Research Spokane Washington 99207 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00228605, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00228605 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →